Assessing Rubrik (RBRK) Valuation After MEDITECH Partnership And Upbeat BTIG Channel Feedback

Rubrik

Rubrik

RBRK

0.00

Rubrik (RBRK) is back in focus after BTIG highlighted strong channel feedback and market share gains. This attention comes just days after Rubrik unveiled a new collaboration with healthcare IT provider MEDITECH.

Rubrik’s recent MEDITECH partnership and upbeat BTIG channel checks come as the stock trades at US$66.59, with a 1 month share price return of 27.37% and a year to date share price decline of 11.77%. The 1 year total shareholder return is down 27.89%, pointing to improving short term momentum against a weaker longer term record.

If this renewed interest in data security has your attention, it could be a good moment to scan other AI driven opportunities with the 46 AI infrastructure stocks

With Rubrik trading at US$66.59, recent gains, ongoing losses of US$348.828m and upbeat channel feedback, the key question is whether the current price still leaves upside or if the market is already pricing in future growth.

Most Popular Narrative: 21% Undervalued

Rubrik's most followed narrative pegs fair value at about $84.07 versus the last close of $66.59, framing the recent rally against a higher long term target built on revenue growth and margin improvement assumptions.

Rubrik's strategic focus on cyber resilience, particularly through innovations like their Rubrik Security Cloud and integration with DSPM, positions them strongly against competitors, suggesting potential future gains in market share and revenue growth.

Rubrik's expanded capabilities in identity recovery and Active Directory forest recovery address critical enterprise needs, providing additional avenues for revenue growth by fulfilling emerging market demands, thereby improving customer retention and net retention rates. Read the complete narrative.

Want to understand why this narrative sees stronger top line growth, rising margins and a rich future earnings multiple all lining up for Rubrik? The core of the thesis hinges on how fast subscription revenue could scale, how far profitability could move from current losses, and what kind of premium investors might pay for that shift. Curious which of those levers does most of the heavy lifting in the fair value math? The full narrative breaks down the exact assumptions driving that $84.07 figure.

Result: Fair Value of $84.07 (UNDERVALUED)

However, this story can change quickly if competition in cyber resilience squeezes margins or if AI and cloud products take longer to gain broad customer adoption.

Another View: Multiples Point To A Richer Price Tag

The analyst and DCF driven fair values suggest upside, but the P/S ratio tells a tougher story. Rubrik trades on about 10.4x sales, compared with a fair ratio of 8.2x, peer average of 7.6x and US Software at 3.7x, which leans toward valuation risk rather than a clear bargain. So which signal do you trust when expectations are this high?

NYSE:RBRK P/S Ratio as at May 2026
NYSE:RBRK P/S Ratio as at May 2026

Next Steps

With mixed signals across valuation, growth expectations, risks and rewards, this is a moment to look closely at the data and decide what it really says to you. You can pressure test that view by reviewing the 2 key rewards and 2 important warning signs

Looking for more investment ideas?

If you are weighing what to do next, do not stop at a single stock when there are plenty of other potential ideas to size up quickly.

  • Target resilience by scanning for companies screened as having stronger fundamentals and balance sheets with the solid balance sheet and fundamentals stocks screener (46 results).
  • Hunt for potential value opportunities by reviewing companies highlighted as 48 high quality undervalued stocks.
  • Pinpoint potential income ideas by checking out companies filtered as 10 dividend fortresses.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.